Adaptive Biotechnologies ... (ADPT)
NASDAQ: ADPT
· Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.05
0.15%
After-hours: Aug 15, 2025, 07:25 PM EDT
Adaptive Biotechnologies Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 58.88M | 52.44M | 47.46M | 46.44M | 43.19M | 41.87M | 45.78M | 37.92M | 48.93M | 37.65M | 55.2M | 47.83M | 43.66M | 38.62M | 37.93M | 39.47M | 38.51M | 38.44M |
Cost of Revenue | 18M | 16.98M | 18.05M | 16.67M | 22.1M | 18.05M | 25.01M | 19.35M | 17.91M | 18.68M | 16.59M | 14.91M | 13.22M | 13.19M | 14.36M | 14.19M | 10.77M | 9.99M |
Gross Profit | 40.88M | 35.46M | 29.41M | 29.77M | 21.09M | 23.82M | 20.78M | 18.57M | 31.02M | 18.97M | 38.61M | 32.92M | 30.44M | 25.43M | 23.57M | 25.28M | 27.74M | 28.45M |
Operating Income | -25.04M | -29.6M | -33.84M | -32.63M | -39.43M | -48.76M | -45.64M | -50.96M | -47.82M | -57.19M | -39.19M | -45.43M | -52.5M | -63.07M | -61.6M | -56.33M | -49.77M | -41.28M |
Interest Income | 2.39M | n/a | 3.07M | 3.47M | 3.77M | 4.22M | 4.61M | 4.28M | 3.61M | 3.02M | 2.6M | 765K | 418K | 271K | 239K | 327K | 464K | 638K |
Pretax Income | -25.59M | -29.85M | -33.72M | -32.07M | -46.25M | -47.53M | -69.47M | -50.3M | -47.81M | -57.7M | -40.17M | -45.32M | -52.08M | -62.8M | -61.36M | -56M | -49.3M | -40.64M |
Net Income | -25.61M | -29.85M | -33.69M | -32.07M | -46.22M | -47.51M | -69.44M | -50.3M | -47.81M | -57.7M | -24.52M | -45.28M | -51.63M | -62.52M | -61.43M | -56M | -49.3M | -40.64M |
Selling & General & Admin | 41.36M | 40.45M | 39.63M | 37.81M | 38.21M | 41.92M | 42.63M | 40.57M | 46.17M | 43.14M | 46.14M | 42.27M | 45.48M | 50.24M | 50.04M | 45.1M | 39.28M | 35.54M |
Research & Development | 24.13M | 24.2M | 23.19M | 24.16M | 22.99M | 30.25M | 23.78M | 28.53M | 32.24M | 32.6M | 31.22M | 35.66M | 37.04M | 37.84M | 34.7M | 36.07M | 37.8M | 33.77M |
Other Expenses | 423K | 419K | 428K | 428K | 7.63M | 423K | n/a | 428K | 423K | 419K | 429K | n/a | 423K | 419K | 429K | 428K | 423K | 419K |
Operating Expenses | 65.92M | 65.07M | 63.25M | 62.4M | 60.52M | 72.58M | 66.42M | 69.53M | 78.83M | 76.16M | 77.8M | 78.35M | 82.94M | 88.5M | 85.17M | 81.6M | 77.5M | 69.73M |
Interest Expense | 2.95M | 2.9M | 2.95M | 2.94M | 2.7M | 2.99M | 3.01M | 3.65M | 3.6M | 3.53M | 3.58M | 653K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 23.57M | 23.05M | 21.57M | 20.55M | 20.31M | 22.32M | 21.91M | 20.49M | 23.87M | 22.31M | 23.72M | 21.51M | 24.28M | 26.09M | 26.7M | 24.95M | 23.22M | 20.6M |
Cost & Expenses | 83.92M | 82.05M | 81.3M | 79.07M | 82.62M | 90.64M | 91.42M | 88.88M | 96.74M | 94.84M | 94.38M | 93.26M | 96.16M | 101.69M | 99.53M | 95.79M | 88.27M | 79.72M |
Income Tax Expense | n/a | n/a | n/a | n/a | -26K | n/a | -26K | -5.76M | n/a | n/a | -15.65M | n/a | -456K | -271K | -182K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 152.08M | 149.19M | 147.1M | 147.52M | 147.41M | 145.79M | 144.9M | 144.7M | 144.4M | 143.51M | 143.05M | 142.93M | 140.66M | 141.7M | 140.21M | 140.83M | 140.36M | 138.97M |
Shares Outstanding (Diluted) | 152.08M | 149.19M | 147.1M | 147.52M | 147.41M | 145.79M | 144.9M | 144.7M | 144.4M | 143.51M | 143.05M | 142.93M | 142.36M | 141.7M | 141.23M | 140.83M | 140.36M | 138.97M |
EPS (Basic) | -0.17 | -0.2 | -0.23 | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 | -0.33 | -0.4 | -0.17 | -0.32 | -0.37 | -0.44 | -0.44 | -0.4 | -0.35 | -0.29 |
EPS (Diluted) | -0.17 | -0.2 | -0.23 | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 | -0.33 | -0.4 | -0.17 | -0.32 | -0.36 | -0.44 | -0.43 | -0.4 | -0.35 | -0.29 |
EBITDA | -18.14M | -29.6M | -26.32M | -24.57M | -38.55M | -39.33M | -61.06M | -39.05M | -36.72M | -48.75M | -29.49M | -40.05M | -45.08M | -55.95M | -56.75M | -50.27M | -46.86M | -38.61M |
EBIT | -22.64M | -32.76M | -30.77M | -29.16M | -43.55M | -44.54M | -66.45M | -46.67M | -44.21M | -54.17M | -36.58M | -44.67M | -52.08M | -62.8M | -61.6M | -56M | -49.77M | -41.28M |
Depreciation & Amortization | 4.5M | 3.15M | 4.45M | 4.59M | 5M | 5.21M | 5.39M | 7.62M | 7.48M | 5.42M | 7.09M | 5.38M | 7M | 6.85M | 6.62M | 5.73M | 4.66M | 4.4M |